Cargando…

Response shift in quality of life assessment among cancer patients: A study from Iran

Background: During the course of disease, particularly of chronic diseases, changes in internal standards cause certain changes in the estimation of quality of life (QOL). These changes indicate the phenomenon of ‘response shift’. The present study aimed at assessing response shift in different scal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Bayan, Nedjat, Saharnaz, Zendehdel, Kazem, Majdzadeh, Reza, Nourmohammadi, Azam, Montazeri, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014782/
https://www.ncbi.nlm.nih.gov/pubmed/29951421
http://dx.doi.org/10.14196/mjiri.31.120
_version_ 1783334289671192576
author Hosseini, Bayan
Nedjat, Saharnaz
Zendehdel, Kazem
Majdzadeh, Reza
Nourmohammadi, Azam
Montazeri, Ali
author_facet Hosseini, Bayan
Nedjat, Saharnaz
Zendehdel, Kazem
Majdzadeh, Reza
Nourmohammadi, Azam
Montazeri, Ali
author_sort Hosseini, Bayan
collection PubMed
description Background: During the course of disease, particularly of chronic diseases, changes in internal standards cause certain changes in the estimation of quality of life (QOL). These changes indicate the phenomenon of ‘response shift’. The present study aimed at assessing response shift in different scales of QOL in Iranian cancer patients. Methods: To assess response shift through the ‘then test’ approach, we asked 211 cancer patients to complete the EORTC QLQ-C30 questionnaire at pretest (at the beginning of the study), posttest (3 months later), and then test (administered immediately after the posttest). Paired t test and Cohen’s effect size were used for comparison. Results: Response shift was significant in all 4 scales under study, i.e. fatigue, pain, emotional functioning, and general QOL (p<0.001). Fatigue, pain, and global QOL have deteriorated significantly with then test approach and emotional function was significantly improved. Conclusion: We observed a response shift in Iranian cancer patients in our study. Thus, in light of the multifactorial nature of QOL and the effect of the response shift bias on different aspects of QOL changes, it is of utmost importance to keep this bias in mind when interpreting the results and managing cancer patients’ treatment regimens.
format Online
Article
Text
id pubmed-6014782
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-60147822018-06-27 Response shift in quality of life assessment among cancer patients: A study from Iran Hosseini, Bayan Nedjat, Saharnaz Zendehdel, Kazem Majdzadeh, Reza Nourmohammadi, Azam Montazeri, Ali Med J Islam Repub Iran Original Article Background: During the course of disease, particularly of chronic diseases, changes in internal standards cause certain changes in the estimation of quality of life (QOL). These changes indicate the phenomenon of ‘response shift’. The present study aimed at assessing response shift in different scales of QOL in Iranian cancer patients. Methods: To assess response shift through the ‘then test’ approach, we asked 211 cancer patients to complete the EORTC QLQ-C30 questionnaire at pretest (at the beginning of the study), posttest (3 months later), and then test (administered immediately after the posttest). Paired t test and Cohen’s effect size were used for comparison. Results: Response shift was significant in all 4 scales under study, i.e. fatigue, pain, emotional functioning, and general QOL (p<0.001). Fatigue, pain, and global QOL have deteriorated significantly with then test approach and emotional function was significantly improved. Conclusion: We observed a response shift in Iranian cancer patients in our study. Thus, in light of the multifactorial nature of QOL and the effect of the response shift bias on different aspects of QOL changes, it is of utmost importance to keep this bias in mind when interpreting the results and managing cancer patients’ treatment regimens. Iran University of Medical Sciences 2017-12-22 /pmc/articles/PMC6014782/ /pubmed/29951421 http://dx.doi.org/10.14196/mjiri.31.120 Text en © 2017 Iran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Hosseini, Bayan
Nedjat, Saharnaz
Zendehdel, Kazem
Majdzadeh, Reza
Nourmohammadi, Azam
Montazeri, Ali
Response shift in quality of life assessment among cancer patients: A study from Iran
title Response shift in quality of life assessment among cancer patients: A study from Iran
title_full Response shift in quality of life assessment among cancer patients: A study from Iran
title_fullStr Response shift in quality of life assessment among cancer patients: A study from Iran
title_full_unstemmed Response shift in quality of life assessment among cancer patients: A study from Iran
title_short Response shift in quality of life assessment among cancer patients: A study from Iran
title_sort response shift in quality of life assessment among cancer patients: a study from iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014782/
https://www.ncbi.nlm.nih.gov/pubmed/29951421
http://dx.doi.org/10.14196/mjiri.31.120
work_keys_str_mv AT hosseinibayan responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran
AT nedjatsaharnaz responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran
AT zendehdelkazem responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran
AT majdzadehreza responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran
AT nourmohammadiazam responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran
AT montazeriali responseshiftinqualityoflifeassessmentamongcancerpatientsastudyfromiran